Catalytic Wealth RIA LLC Purchases 807 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Catalytic Wealth RIA LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 8.8% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 9,959 shares of the healthcare conglomerate’s stock after acquiring an additional 807 shares during the quarter. UnitedHealth Group accounts for 1.0% of Catalytic Wealth RIA LLC’s investment portfolio, making the stock its 22nd biggest holding. Catalytic Wealth RIA LLC’s holdings in UnitedHealth Group were worth $5,823,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of UNH. Delta Financial Group Inc. raised its holdings in UnitedHealth Group by 1.0% in the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after acquiring an additional 17 shares during the last quarter. Signature Resources Capital Management LLC raised its position in UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 18 shares during the last quarter. Saxony Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 3.5% during the 2nd quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock valued at $270,000 after acquiring an additional 18 shares during the last quarter. GoalVest Advisory LLC raised its holdings in shares of UnitedHealth Group by 0.6% during the second quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after purchasing an additional 18 shares during the last quarter. Finally, Fiduciary Group LLC boosted its holdings in UnitedHealth Group by 0.5% in the second quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after purchasing an additional 18 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UNH opened at $615.81 on Monday. The stock has a market capitalization of $566.72 billion, a price-to-earnings ratio of 40.12, a PEG ratio of 1.81 and a beta of 0.58. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $619.80. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. The company has a fifty day moving average of $581.93 and a 200 day moving average of $545.85.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter last year, the business posted $6.56 EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.36%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Upgrades and Downgrades

UNH has been the topic of several research analyst reports. Morgan Stanley lowered their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. KeyCorp began coverage on UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 price target for the company. Barclays dropped their price objective on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 24th. Finally, Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.